NR1H4 and Alzheimer disease: Chen et al. [147] investigated the effect of FXR agonist 6ECDCA on AD, and found that the FXR mRNA and protein expression levels were enhanced in apoptotic neurons with excessive Aβ1–42 deposition in human neuroblastoma differentiated cells and mouse hippocampal neurons, respectively.